Arkolith/Insider Trading/CATX/Form 4

Puhlmann Markus

Chief Medical OfficerPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Dec 19, 2023
Net Buying
Open-Market Buys
$188K
Open-Market Sells
$0
Net Open-Market Flow
$188K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2023Buy(P)400K$0.34$136K1.1M
Dec 18, 2023Buy(P)60K$0.26$16K695K
Dec 15, 2023Buy(P)135K$0.27$36K635K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-23-034931) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML